Women Health Devices Market Size & Share 2026-2035

Women Health Devices Market Size

The global women health devices market was valued at USD 150.4 billion in 2025 and is projected to grow from USD 162.7 billion in 2026 to USD 389.8 billion by 2035, expanding at a CAGR of 10.2%, according to the latest report published by Global Market Insights Inc.

This strong growth is driven by the rising prevalence of gynecological disorders and chronic conditions among women, increasing awareness and adoption of preventive healthcare, growing demand for minimally invasive diagnostic and therapeutic solutions, and continuous technological advancements in wearable health monitors, fertility tracking devices, and imaging systems.

The market increased from USD 121.3 billion in 2022 to USD 139.4 billion in 2024. The growing prevalence of women-specific health conditions in developed nations is a major driver for the women’s health devices market. Diseases such as breast cancer, cervical cancer, endometriosis, osteoporosis, and polycystic ovary syndrome (PCOS) are increasingly being diagnosed, requiring advanced diagnostic and therapeutic devices. For instance, breast cancer remains the most common cancer among women globally, and early detection through digital mammography and imaging devices is critical for improving survival rates. Similarly, fertility-related disorders and complications during pregnancy have led to a surge in demand for assisted reproductive technologies and maternal care devices. According to the World Health Organization (WHO), breast cancer alone accounted for an estimated 670 000 deaths globally in 2022. This rising disease burden underscores the need for innovative solutions such as minimally invasive surgical tools, advanced imaging systems, and home-based monitoring devices to improve women’s health outcomes. Consequently, healthcare providers and governments are investing heavily in preventive care and early diagnosis technologies, fueling market growth.

Besides that, the increase in the elderly female population is another significant factor driving the women’s health devices market. Aging women are more susceptible to chronic conditions such as osteoporosis, urinary incontinence, and gynecological cancers, which require specialized diagnostic and therapeutic devices. According to WHO, by 2030, one in six people globally will be aged 60 years or older. This demographic shift is expected to increase demand for bone density scanners, hormone replacement therapy devices, pelvic health solutions, and minimally invasive surgical instruments. Furthermore, elderly women often require long-term care and monitoring, creating opportunities for home healthcare devices and remote patient monitoring solutions tailored to women’s health needs. Healthcare systems worldwide are implementing initiatives to address these challenges, including improved access to screening programs and advanced treatment options for age-related conditions. The growing elderly female population amplifies the need for comprehensive women’s health solutions, making this segment a critical focus for device manufacturers and healthcare providers.
 

Women’s health devices market refers to the segment of medical devices designed specifically to address health conditions, wellness needs, and diagnostic requirements unique to women. These devices include products for reproductive health, pregnancy and childbirth, fertility monitoring, menstrual care, breast health, and other areas impacting women’s overall well-being.

Women Health Devices Market Trends

• The demand for women’s health devices is growing quickly as more women face health challenges such as breast cancer, gynecological disorders, and fertility issues. In developed countries, this rising disease burden is pushing healthcare providers to adopt devices that help with early detection, accurate diagnosis, and better treatment. These devices are no longer just basic tools, they are becoming smarter and more efficient, thanks to technology.
   
• Modern women’s health devices now include features like automation and AI to make processes faster and reduce errors. For example, advanced imaging systems used in obstetrics and gynecology can automatically measure and document results, saving time for doctors and improving accuracy. Similarly, remote monitoring solutions allow pregnant women to track fetal health from home, reducing hospital visits and improving convenience.
   
• Digital health tools are also playing a big role. Apps for menstrual cycle tracking and fertility monitoring are widely used, and some even offer FDA-approved digital contraception options. These tools help women manage their health independently and connect with doctors when needed. This combination of clinical devices and consumer apps is creating a more connected and personalized healthcare experience.
   
• In developing countries, awareness programs about reproductive health, menstrual hygiene, and preventive screening for cervical and breast cancer are increasing adoption of women’s health devices. Global initiatives by organizations like WHO and UNICEF are promoting screening and education, which is driving demand for affordable diagnostic tools and self-care products in these regions.

• Overall, the women’s health devices market is moving toward integrated, smart solutions that combine imaging, monitoring, and digital platforms.
   

Women Health Devices Market Analysis

Based on product, the market is segmented into devices and consumables. The devices segment was valued at USD 113.7 billion in 2025 and held a significant market share of 75.6%. The devices segment was further bifurcated into contraceptive devices, fertility monitoring devices, menstrual health products, breast health devices, pelvic health devices, maternal health products, general health monitoring devices, medical devices for gynecological conditions and other devices.
 

• Growth in this segment is supported by rising awareness among women about preventive healthcare and the availability of specialized devices that enable early diagnosis and self-management.

• Technological advancements have made these products more efficient, accurate, and user-friendly, driving adoption in both clinical and home settings. Devices such as fertility monitors, menstrual health trackers, breast imaging systems, and maternal monitoring tools are increasingly integrated with digital platforms, offering real-time data and personalized care.
   
• In addition, favorable regulatory policies, expanding product portfolios, and increased investment in women’s health research are accelerating innovation.
   
• Higher healthcare spending globally and a shift toward proactive health management further strengthen demand for these devices. As a result, the devices segment continues to dominate the market, supported by technology-driven solutions that improve accessibility, convenience, and patient outcomes.
   

Based on applications, the women health devices market is segmented into cancer, osteoporosis, infectious disease, uterine fibroids, pregnancy, female sterilization, menstrual disorders and other applications. The cancer segment was valued at USD 64.3 billion in 2025.
 

• This dominance is driven by the high global burden of cancer among women, particularly breast cancer. According to WHO as reported in 2025, breast cancer caused an estimated 670,000 deaths globally in 2022, making it the most common cancer in women in 157 out of 185 countries. Notably, roughly half of all breast cancers occur in women with no specific risk factors other than sex and age, highlighting the need for widespread screening and early detection.
   
• These alarming statistics underscore the critical importance of advanced diagnostic and monitoring devices. Hospitals, clinics, and outpatient facilities are increasingly adopting technologies for breast imaging, biopsy, and cancer staging to improve survival rates through early intervention. The growing emphasis on preventive healthcare and awareness campaigns further accelerates demand for these solutions.
   
• Moreover, industry players are investing heavily in innovation to meet this demand, expanding portfolios to include integrated imaging, diagnostic, and surgical solutions. Favourable regulatory policies and rising healthcare expenditures globally further strengthen market growth. As a result, the cancer segment remains a cornerstone of the women’s health devices market, driven by the urgent need for early detection and improved outcomes in oncology.
  
            
  
  Learn more about the key segments shaping this market

  Download Free PDF

Based on end use, the women health devices market is segmented into hospitals, obstetrics and gynecology clinics, diagnostic laboratories, ambulatory surgical centers and other end users. The hospitals segment held a significant market share of 31.2% in 2025.
 

• This segment’s growth is primarily attributed to high patient volumes, frequent surgical procedures, and the need for comprehensive diagnostic and treatment solutions for women’s health conditions. Hospitals remain the primary setting for advanced imaging, maternal monitoring, gynecological surgeries, and cancer diagnostics, which require sophisticated devices and integrated care systems.
   
• The complexity of care delivery in hospitals, combined with rising admissions for obstetric and gynecological procedures, drives demand for reliable and efficient devices. Hospitals also adhere to stringent regulatory and accreditation standards, ensuring the use of approved technologies for patient safety and quality outcomes.
   
• These factors encourage investment in advanced imaging platforms, minimally invasive surgical tools, and connected monitoring systems that support real-time data integration and workflow efficiency.
   
• As surgical volumes and critical care needs continue to rise globally, hospitals will remain a key consumer of women’s health devices.
   

North America Women Health Devices Market

• The North America region accounted for 32.1% of the global women health devices industry share  in 2025. North America continues to hold a leading position in the global women’s health devices market, supported by advanced healthcare infrastructure, high awareness levels, and strong regulatory frameworks. A major growth driver is the rising prevalence of women-specific health conditions, particularly breast cancer. According to Canadian health data, breast cancer is the most common cancer among women in Canada and the second leading cause of cancer-related deaths. It is estimated that 1 in 8 women in Canada will develop breast cancer during their lifetime, and 1 in 35 will die from it. On average, 87 women are diagnosed with breast cancer every day, and 15 women die from the disease daily.
   
• These alarming statistics underscore the critical need for early detection and advanced diagnostic solutions, driving demand for breast imaging systems, biopsy devices, and related technologies across hospitals and clinics.
   

• With continuous technological advancements, robust clinical standards, and expanding healthcare infrastructure, North America is expected to maintain its dominant position in the women’s health devices market throughout the forecast period.
   

The U.S. women health devices market was valued at USD 34.9 billion and USD 37.4 billion in 2022 and 2023, respectively. The market size reached USD 43.1 billion in 2025, growing from USD 40 billion in 2024.
 

• The U.S. represents a major share of the global women’s health devices market, supported by advanced healthcare infrastructure, high awareness levels, and strong regulatory frameworks. A key growth driver is the rising prevalence of breast cancer, which remains a critical health concern.
   
• According to the Centers for Disease Control and Prevention (CDC), 279,731 new breast cancer cases were reported among women in the U.S. in 2022, and 42,213 women died from breast cancer in 2023. These figures highlight the urgent need for effective screening, diagnostic, and treatment solutions.
   
• The high incidence of breast cancer, combined with growing demand for preventive care and early detection, is driving adoption of advanced imaging systems, biopsy devices, and minimally invasive surgical tools across hospitals and clinics. In addition, strong regulatory oversight by agencies such as the FDA and investments in innovative technologies for cancer care, maternal health, and gynecological procedures.
   
• Continuous technological advancements, integration of AI in imaging, and expansion of remote monitoring solutions further strengthen the U.S. market. With robust clinical standards, high patient volumes, and ongoing investment in women’s health research, the U.S. is expected to maintain its leading position in the global women’s health devices market throughout the forecast period.
   

Europe Women Health Devices Market

Europe women health devices industry accounted for USD 43.6 billion in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• A major growth driver is the rising burden of cancer among women. According to the European Cancer Organisation, an estimated 12 million women in Europe are currently living with cancer, with 1.2 million new cases diagnosed each year and nearly 600,000 deaths annually. These figures highlight the urgent need for effective screening, diagnostic, and treatment solutions across the region.
   
• The high prevalence of breast and gynecological cancers, combined with increasing adoption of preventive healthcare practices, is driving demand for advanced devices. Government-backed initiatives promoting cancer screening programs and women’s health awareness further strengthen market growth.
   
• With continuous technological advancements, strong clinical standards, and expanding healthcare investments, Europe is expected to maintain a significant position in the global women’s health devices market throughout the forecast period.
   

Germany's women health devices market is projected to experience steady growth between 2026 and 2035.
 

• Germany is a key contributor to the European women’s health devices market, supported by strong healthcare infrastructure and well-established national screening programs.
   
• Breast cancer remains the most common cancer among women in the country, with approximately 74,500 new cases reported in 2022, along with over 6,000 diagnoses of in situ breast tumors. Cervical cancer also poses a significant health challenge, with 4,388 new cases recorded in the same year. These figures highlight the growing need for advanced diagnostic and treatment solutions.
   
• Germany’s healthcare system places a strong emphasis on early detection and preventive care, which is driving adoption of high-performance imaging technologies, diagnostic platforms, and minimally invasive surgical devices.
   
• National cancer screening programs, combined with public awareness campaigns, have increased participation in routine breast and cervical cancer checks, creating consistent demand for innovative solutions.
   
• With a focus on precision diagnostics, technology-driven workflows, and preventive healthcare, Germany is expected to maintain its strong position in the European women’s health devices market throughout the forecast period.
   

Asia Pacific Women Health Devices Market

The Asia Pacific region is projected to show a lucrative growth of about 10.6% during the forecast period.
 

• Breast cancer remains a major health concern across Asia Pacific, with 2.3 million new cases diagnosed globally in 2020, accounting for 24.5% of all female cancers. Notably, close to half (45.4%) of these cases were reported in Asia, as highlighted in a 2022 NIH article. This high disease burden underscores the urgent need for advanced screening, diagnostic, and treatment solutions tailored to women’s health.
   
• Rising breast cancer incidence, coupled with growing awareness of early detection, is driving demand for mammography systems, breast biopsy devices, and minimally invasive surgical tools across the region.
   
• In addition to cancer care, Asia Pacific’s women’s health device market is supported by expanding maternal health programs, fertility treatment adoption, and increasing prevalence of gynecological disorders. The region’s large population base, improving healthcare infrastructure, and rising disposable incomes are accelerating uptake of contraceptive devices, fetal monitoring systems, and pelvic health solutions.
   
• With high breast cancer incidence, growing awareness of preventive care, and continuous technological advancements, Asia Pacific is expected to emerge as one of the fastest-growing regions in the global women’s health devices market throughout the forecast period.
   

China women health devices market is poised to witness lucrative growth between 2026 - 2035.
 

• Breast cancer poses a significant health challenge in China, with approximately 303,600 new cases and 70,400 deaths reported by NIH in 2021 article. Of these, 205,100 cases and 45,100 deaths occurred in urban areas, while 98,500 cases and 24,500 deaths were from rural regions. This urban-rural disparity highlights the need for equitable access to advanced diagnostic and treatment solutions across the country.
   
• Rising breast cancer incidence, combined with growing awareness of early detection, is driving demand for mammography systems, breast biopsy devices, and minimally invasive surgical tools. Urban centers are witnessing rapid adoption of digital breast imaging and AI-powered diagnostic platforms.
   
• Also, government policies such as the “Healthy China 2030” plan emphasize preventive care and improved healthcare access for women. These initiatives, backed by increased healthcare spending and stricter compliance requirements, create strong growth opportunities for manufacturers of advanced women’s health devices.
   

Latin America Women Health Devices Market

Brazil is experiencing significant growth in the women health devices industry
 

• The growth of Brazil’s women’s health devices market is strongly driven by rising breast cancer incidence, demographic shifts, and modernization of healthcare infrastructure.
   
• In 2022, an estimated 94,728 new cases of breast cancer were reported, corresponding to an adjusted incidence rate of 43.74 cases per 100,000 women, according to the European Society of Medicine. This high disease burden underscores the need for advanced screening and diagnostic solutions across the country.
   
• Brazil’s population is aging rapidly, with the share of individuals aged 65 and older projected to triple by 2050, significantly increasing vulnerability to chronic conditions and cancer. This demographic trend is fuelling demand for mammography systems, breast biopsy devices, and minimally invasive surgical tools, alongside broader women’s health solutions such as contraceptive devices, fetal monitoring systems, and pelvic health products.
   
• With the integration of smart diagnostic systems, telehealth-enabled solutions, and cloud-based compliance tracking, Brazil is strengthening its healthcare resilience and supporting patient safety. Combined with government initiatives to improve cancer care and maternal health, these factors ensure sustained market growth for women’s health device manufacturers.
   

Middle East and Africa Women Health Devices Market

• Breast cancer is the most commonly diagnosed cancer in Saudi Arabia and the second-leading cause of cancer-related death after leukemia, underscoring the urgent need for advanced women’s health solutions. This high disease burden is driving demand for early detection technologies, diagnostic imaging systems, and minimally invasive treatment devices across the country.
   
• Saudi Arabia is steadily increasing healthcare investments under Vision 2030, which prioritizes modernization of hospitals, diagnostic centers, and specialized women’s health facilities. These initiatives are creating a strong foundation for adopting digital mammography systems, AI-powered diagnostic platforms, and portable screening devices, ensuring improved accessibility and compliance with international standards.
   
• Rising healthcare spending and a growing focus on preventive care are accelerating the adoption of innovative technologies, including smart imaging systems, telehealth-enabled diagnostic tools, and integrated compliance monitoring solutions. These advancements support better patient outcomes and help address disparities in breast cancer care across urban and rural regions.
   
• Government-led programs emphasizing women’s health, cancer prevention, and early screening are backed by increased funding and stricter regulatory compliance, creating significant growth opportunities for manufacturers of advanced women’s health devices in Saudi Arabia.
   

Women Health Devices Market Share

• Leading companies in the women’s health devices market are actively strengthening their global presence through strategic acquisitions, partnerships, and technology-driven collaborations. These initiatives aim to secure long-term growth and address the rising demand for advanced solutions in breast health, maternal care, fertility, and gynecological health. Top five players GE Healthcare Technologies, Hologic, Koninklijke Philips N.V., Samsung Electronics, and The Cooper Companies collectively hold a market share of approximately 55% in the global women’s health devices market.
   
• Their product portfolios encompass a wide range of innovative solutions, including digital mammography systems, breast biopsy devices, ultrasound imaging platforms, fetal monitoring systems, and contraceptive devices. By integrating AI-powered diagnostics, automation, and telehealth capabilities, these companies are enabling healthcare providers to improve early detection, enhance patient outcomes, and streamline workflows in women’s health.
   
• Close collaboration with hospitals, diagnostic centers, and regulatory authorities remains central to their strategy, ensuring compliance with stringent quality standards and expanding access to advanced women’s health technologies. At the same time, these players are accelerating penetration in emerging markets and supporting healthcare infrastructure modernization, making preventive and diagnostic solutions more accessible worldwide.
   

Women Health Devices Market Companies

Few of the prominent players operating in the infection control supplies industry include:

• Allengers
• Ava Women
• Caldera Medical
• Carestream Health
• Garmin Ltd.
• GE Healthcare Technologies
• HeraMED
• Hologic
• Koninklijke Philips N.V.
• Mankind Pharma Limited
• Pregnabit
• Samsung Electronics
• The Cooper Companies
   

· Samsung Electronics
 

Samsung Electronics, through its Samsung Medison division, is a key innovator in women’s health imaging solutions. The company offers advanced ultrasound platforms such as the HERA W10 Elite, which delivers sophisticated obstetrics and gynecology capabilities for high-precision maternal and fetal assessments.
 

· Hologic
 

Hologic is recognized worldwide for its leadership in breast health and minimally invasive gynecological treatment technologies, offering advanced solutions such as the 3Dimensions Mammography System for high-precision breast cancer screening and the Acessa Laparoscopic Radiofrequency Ablation (Lap-RFA) system for treating uterine fibroids. The company focuses on early detection and minimally invasive procedures, ensuring improved patient outcomes and streamlined workflows for healthcare providers.
 

· The Cooper Companies
 

The Cooper Companies specializes in reproductive health and contraceptive solutions, with a robust portfolio that includes intrauterine devices (IUDs), fertility monitoring systems, and gynecological surgical instruments. The company prioritizes patient safety, comfort, and long-term reliability, supporting healthcare providers in delivering effective women’s health interventions.
 

Women Health Devices industry News:

• In February 2024, Hologic, Inc. announced that its new Genius Digital Diagnostics System with the Genius Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration (FDA), making it the first and only FDA-cleared digital cytology system that combines deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells. This approval enabled the company to gain competitive edge over its peers.
   
• In March 2021, Garmin Ltd. launched a smartwatch - ‘Lily’ for women. Lily offers women’s health features, including menstrual cycle tracking and newly launched pregnancy tracking feature sharing mother-to-be a snapshot of their pregnancy alongside their other health, wellness and activity data. This product launch helped the company to acquire enhanced customer base.
   

The women health devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

 

Market, By Product

• Devices
  • Contraceptive devices
  • Fertility monitoring devices
  • Menstrual health products
  • Breast health devices
  • Pelvic health devices
  • Maternal health products
  • General health monitoring devices
  • Medical devices for gynecological conditions
  • Other devices
• Consumables

Market, By Application

• Cancer
• Osteoporosis
• Infectious disease
• Uterine fibroids
• Pregnancy
• Female sterilization
• Menstrual disorders
• Other applications

Market, By End Use

• Hospitals
• Obstetrics and gynecology clinics
• Diagnostic laboratories
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE